Literature DB >> 25006437

MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).

Thomas Thum1, Sandor Batkai2.   

Abstract

MicroRNAs (miRNAs) are molecules increasingly investigated for both diagnostic and therapeutic strategies. Whereas information about their role in the left ventricle has been studied for many years, there is scarce information about the right ventricle. We thus here review known details about the expression, regulation, and function of miRNAs in right heart diseases. Current identified therapeutic strategies using miRNA modulators to treat pulmonary hypertension and thus also having beneficial effects on the right ventricle are also discussed. Finally, the current knowledge about the diagnostic and predictive use of circulating miRNAs in patients with pulmonary hypertension and right ventricular failure is presented. There is strong hope that the increasing knowledge about miRNAs in the right heart will finally help to improve the treatment of patients with pulmonary and right ventricular heart diseases.

Entities:  

Keywords:  gene expression; gene regulation; genetics of cardiovascular disease; remodeling

Year:  2014        PMID: 25006437      PMCID: PMC4070782          DOI: 10.1086/675981

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  34 in total

1.  MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

Authors:  Victoria N Parikh; Richard C Jin; Sabrina Rabello; Natali Gulbahce; Kevin White; Andrew Hale; Katherine A Cottrill; Rahamthulla S Shaik; Aaron B Waxman; Ying-Yi Zhang; Bradley A Maron; Jochen C Hartner; Yuko Fujiwara; Stuart H Orkin; Kathleen J Haley; Albert-László Barabási; Joseph Loscalzo; Stephen Y Chan
Journal:  Circulation       Date:  2012-02-27       Impact factor: 29.690

Review 2.  microRNA therapeutics in cardiovascular disease models.

Authors:  Seema Dangwal; Thomas Thum
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-02       Impact factor: 13.820

3.  The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C.

Authors:  Lei Guo; Zhaoping Qiu; Liuping Wei; Xiufeng Yu; Xu Gao; Shulin Jiang; Hai Tian; Chun Jiang; Daling Zhu
Journal:  Hypertension       Date:  2012-03-05       Impact factor: 10.190

4.  A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Authors:  Paola Caruso; Yvonne Dempsie; Hannah C Stevens; Robert A McDonald; Lu Long; Ruifang Lu; Kevin White; Kirsty M Mair; John D McClure; Mark Southwood; Paul Upton; Mei Xin; Eva van Rooij; Eric N Olson; Nicholas W Morrell; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

5.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

6.  Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.

Authors:  Matthias Brock; Michelle Trenkmann; Renate E Gay; Beat A Michel; Steffen Gay; Manuel Fischler; Silvia Ulrich; Rudolf Speich; Lars C Huber
Journal:  Circ Res       Date:  2009-04-23       Impact factor: 17.367

7.  Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

Authors:  Changjin Lee; S Alex Mitsialis; Muhammad Aslam; Sally H Vitali; Eleni Vergadi; Georgios Konstantinou; Konstantinos Sdrimas; Angeles Fernandez-Gonzalez; Stella Kourembanas
Journal:  Circulation       Date:  2012-10-31       Impact factor: 29.690

8.  Role for miR-204 in human pulmonary arterial hypertension.

Authors:  Audrey Courboulin; Roxane Paulin; Nellie J Giguère; Nehmé Saksouk; Tanya Perreault; Jolyane Meloche; Eric R Paquet; Sabrina Biardel; Steeve Provencher; Jacques Côté; Martin J Simard; Sébastien Bonnet
Journal:  J Exp Med       Date:  2011-02-14       Impact factor: 14.307

9.  Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation.

Authors:  Samuel Jalali; Gurukumar K Ramanathan; Prasanna Tamarapu Parthasarathy; Salman Aljubran; Lakshmi Galam; Asfiya Yunus; Sara Garcia; Ruan R Cox; Richard F Lockey; Narasaiah Kolliputi
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.

Authors:  Jongmin Kim; Yujung Kang; Yoko Kojima; Janet K Lighthouse; Xiaoyue Hu; Micheala A Aldred; Danielle L McLean; Hyekyung Park; Suzy A Comhair; Daniel M Greif; Serpil C Erzurum; Hyung J Chun
Journal:  Nat Med       Date:  2012-12-23       Impact factor: 53.440

View more
  9 in total

1.  Right ventricular long noncoding RNA expression in human heart failure.

Authors:  Thomas G Di Salvo; Yan Guo; Yan Ru Su; Travis Clark; Evan Brittain; Tarek Absi; Simon Maltais; Anna Hemnes
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

2.  Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.

Authors:  Hyung J Chun; Sébastien Bonnet; Stephen Y Chan
Journal:  Am J Respir Crit Care Med       Date:  2017-01-15       Impact factor: 21.405

Review 3.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

Review 4.  Discerning functional hierarchies of microRNAs in pulmonary hypertension.

Authors:  Vinny Negi; Stephen Y Chan
Journal:  JCI Insight       Date:  2017-03-09

Review 5.  Molecular Mechanisms of Right Ventricular Failure.

Authors:  Sushma Reddy; Daniel Bernstein
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 6.  lncRNA/MicroRNA interactions in the vasculature.

Authors:  M D Ballantyne; R A McDonald; A H Baker
Journal:  Clin Pharmacol Ther       Date:  2016-03-31       Impact factor: 6.875

7.  The left ventricle undergoes biomechanical and gene expression changes in response to increased right ventricular pressure overload.

Authors:  Vitaly O Kheyfets; Melanie J Dufva; Mario Boehm; Xuefeit Tian; Xulei Qin; Jennifer E Tabakh; Uyen Truong; Dunbar Ivy; Edda Spiekerkoetter
Journal:  Physiol Rep       Date:  2020-05

8.  RNA expression profiles and regulatory networks in human right ventricular hypertrophy due to high pressure load.

Authors:  Philippe Chouvarine; Joachim Photiadis; Robert Cesnjevar; Jens Scheewe; Ulrike M M Bauer; Thomas Pickardt; Hans-Heiner Kramer; Sven Dittrich; Felix Berger; Georg Hansmann
Journal:  iScience       Date:  2021-02-27

Review 9.  Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?

Authors:  Jordy M M Kocken; Paula A da Costa Martins
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.